Registro:

Referencias:

• Gasser, C., Gautier, C., Steck, A., Hamolytisch-uramische syndrome. Bilateral niereninsenhe krosen bei akuten erworbenen hamolytischn anamien (1955) Schweiz Med Wochenschr, 85, pp. 905-909
• Gianantonio, C., Vitacco, M., Mendilaharzu, J., The hemolytic uremic syndrome (1964) J Pediatr, 64, pp. 478-485
• Siegler, R.L., The hemolytic uremic syndrome (1995) Pediatr Clin North Am, 42, pp. 1505-1525
• Gianantonio, C., Vitacco, M., Mendilaharzu, F., The hemolytic uremic syndrome (1973) Nephron, 11, pp. 174-192
• López, E.L., Contrini, M.M., Devoto, S., Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea (1995) J Pediatr, 127, pp. 364-367
• Remuzzi, G., Ruggenenti, P., The hemolytic uremic syndrome (1995) Kidney Int, 47, pp. 2-19
• Clealy, T.G., Cytotoxin producing escherichia coli and the haemolytic uremic syndrome (1988) Pediatr Clin North Am, 35, pp. 485-501
• Kaplan, B.S., Proesmans, W., The hemolytic syndrome of childhood and its variants (1987) Semin Hematol, 24, pp. 148-160
• Karmali, M.A., Steele, B.T., Petric, M., Sporadic cases of haemolytic uremic syndrome associated with faecal cytotoxin and cytotoxin producing escherichia coli in stools (1983) Lancet, 1, pp. 619-620
• Karmali, M.A., Petric, M., Lim, C., The association between hemolytic uremic syndrome and infection by verotoxin producing escherichia coli (1985) J Infect Dis, 151, pp. 775-782
• Obrig, T., Louise, C., Lingwood, C., Endothelial heterogeneity in Shiga toxin receptors and responses (1995) J Biol Chem, 268, pp. 15484-15488
• Waddell, T., Cohen, A., Lingwood, C.A., Induction of verotoxin sensitivity in receptor deficient cell lines using the receptor glycolipid globotriosylceramide (1990) Proc Natl Acad Sci U S A, 87, pp. 7898-7901
• Boyd, B., Lingwood, C., Verotoxin receptor glycolipid in human renal tissue (1989) Nephron, 51, pp. 207-210
• Van De Kar, N., Kooistra, T., Vermeer, M., Tumor necrosis factor and interleukin-1 induces expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome (1992) Blood, 80, pp. 2755-2764
• Moake, J.L., Byrnes, J.J., Troll, J.H., Abnormal VIII:Von Willebrand factor patterns in the plasma of patients with the hemolytic uremic syndrome (1984) Blood, 64, pp. 592-598
• Remuzzi, G., Misiani, R., Marchesi, D., Haemolytic uremic syndrome. Deficiency of plasma factors regulating prostcyclin activity (1978) Lancet, 2, pp. 871-872
• Levin, M., Elkon, K.B., Nokes, T.J.C., Inhibitor of prostacyclin production in sporadic haemolytic syndrome (1983) Arch Dis Child, 58, pp. 703-708
• Gordon, L.I., Cancer and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (1997) Semin Hematol, 34, pp. 159-166
• Schriber, J.R., Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (1997) Semin Hematol, 34, pp. 126-133
• Groff, J.A., Kozak, M., Boehmer, J.P., Endotheliopathy: Acontinuum of hemolytic uremic syndrome due to mitomycin therapy (1997) Am J Kidney Dis, 29, pp. 280-284
• Fong, J.S.C., Kaplan, B.S., Impairment of platelet aggregation in hemolytic uremic syndrome. Evidence for platelet "exhaustion." (1982) Blood, 60, pp. 564-570
• Vizcargüénaga, M.I., Sanchez Avalos, J.C., Montes De Oca, M., Estudio de la agregación plaquetaria en SUH (1983) Medicina, 43, pp. 853-854
• Kordich, L.C., Bergonzelli, G., Lago, O., Altered immunoelectrophoretic profiles of fibrinogen in full-term newborns (1986) Thromb Res, 44, pp. 695-700
• Born, G.V.R., Cross, M.J., The aggregation of blood platelets (1963) J Physiol, 168, p. 178
• Markwell, M.A., Haas, S.M., Lieber, L.L., Modification of the lowry procedure to simplify protein determination in membrane lipoprotein samples (1978) Anal Biochem, 87, pp. 206-210
• Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685
• Towbin, H., Stachlin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications (1979) Proc Natl Acad Sci U S A, 76, pp. 4350-4354
• Duperray, A., Berthier, R., Chagnon, E., Biosynthesis and processing of platelet GPIIbIIIa in human megakaryocytes (1987) J Cell Biol, 104, pp. 1665-1673
• Noris, M., Ruggenenti, P., Todeschini, M., Increased nitric oxide formation in recurrent thrombotic microangiopathies: A possible mediator of microvascular injury (1996) Am J Kidney Dis, 27, pp. 790-796
• Monteagudo, J., Pereira, A., Reverter, J.C., Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome (1991) Thromb Haemost, 60, pp. 515-519
• Marta, R., Florentini, L., Diaz, M., Increased thrombin generation markers and TNF levels in children with epidemic thrombotic microangiopathy (1998) Medicina, 58, pp. 8-12
• Mannucci, P.M., Lombardi, R., Lattuada, A., Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome (1989) Blood, 74, pp. 978-983
• Nevard, C., Jurd, K., Lane, D., Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome (1997) Thromb Haemost, 78, pp. 1450-1455
• Turi, S., Nemeth, I., Vargha, I., Oxidative damage of red blood cells in haemolytic uraemic syndrome (1994) Pediatr Nephrol, 8, pp. 26-29
• Facorro, G., Aguirre, F., Florentini, L., Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome (1997) Acta Physiol Pharmacol Ther Latinoam, 47, pp. 137-146
• Kroll, M.H., Hellenus, J.D., Mc Intire, L.V., Platelets and shear stress (1996) Blood, 88, pp. 1525-1541
• Sreedhara, R., Itagaki, I., Hakim, R.M., Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIbIIIa receptors (1996) Am J Kidney Dis, 27, pp. 355-364
• Sreedhara, R., Itagaki, I., Byron Lynn, B.S., Defective platelet aggregation in uremia is transiently worsened by hemodialysis (1995) Am J Kidney Dis, 25, pp. 555-563

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------